Bicara Therapeutics/$BCAX
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Bicara Therapeutics
Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b.
Ticker
$BCAX
Sector
Primary listing
Employees
55
Headquarters
Website
BCAX Metrics
BasicAdvanced
$781M
-
-$2.23
-
-
Price and volume
Market cap
$781M
52-week high
$24.09
52-week low
$7.80
Average daily volume
733K
Financial strength
Current ratio
14.142
Quick ratio
13.799
Long term debt to equity
0.218
Total debt to equity
0.49
Profitability
EBITDA (TTM)
-141.042
Effective tax rate (TTM)
-0.29%
Management effectiveness
Return on assets (TTM)
-18.59%
Return on equity (TTM)
-26.64%
Valuation
Price to book
1.93
Price to tangible book (TTM)
1.93
Price to free cash flow (TTM)
-6.882
Free cash flow yield (TTM)
-14.53%
Free cash flow per share (TTM)
-2.072
Growth
Earnings per share change (TTM)
-87.69%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Bicara Therapeutics stock?
Bicara Therapeutics (BCAX) has a market cap of $781M as of November 14, 2025.
What is the P/E ratio for Bicara Therapeutics stock?
The price to earnings (P/E) ratio for Bicara Therapeutics (BCAX) stock is 0 as of November 14, 2025.
Does Bicara Therapeutics stock pay dividends?
No, Bicara Therapeutics (BCAX) stock does not pay dividends to its shareholders as of November 14, 2025.
When is the next Bicara Therapeutics dividend payment date?
Bicara Therapeutics (BCAX) stock does not pay dividends to its shareholders.
What is the beta indicator for Bicara Therapeutics?
Bicara Therapeutics (BCAX) does not currently have a Beta indicator.